Cancerous miRNAs and their regulation

Xu-Bao Shi1, Clifford G Tepper, Ralph W deVere White

  • 1Department of Urology, University of California, Davis, School of Medicine, Sacramento, California 95817, USA.

Insights

MicroRNAs (miRNAs) are key gene regulators in development and cancer. Aberrant miRNA expression drives tumor growth, metastasis, and therapy resistance, making them promising cancer biomarkers and therapeutic targets.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) are crucial regulators of gene expression, impacting cellular processes like proliferation, differentiation, and apoptosis.
  • Aberrant miRNA expression is linked to various human cancers, where they can act as proto-oncogenes or tumor suppressors.

Purpose of the Study:

  • To review recently identified cancer-associated miRNAs and their roles in human cancer pathogenesis.
  • To discuss the regulatory mechanisms of these miRNAs, including key transcription factors.

Main Methods:

  • Literature review of recent studies on cancer-associated miRNAs.
  • Analysis of miRNA roles in tumor initiation, progression, metastasis, and therapy resistance.
  • Examination of signaling pathways and transcription factors (Myc, p53, androgen receptor) regulating miRNA expression.

Main Results:

  • Cancer-associated miRNAs are implicated in uncontrolled proliferation, survival, inhibited differentiation, and invasive behavior.
  • Deregulation of specific miRNAs contributes significantly to tumor initiation and progression.
  • These miRNAs influence metastasis and therapy resistance, highlighting their clinical relevance.

Conclusions:

  • Cancer-associated miRNAs are pivotal in human cancer development and progression.
  • They represent valuable biomarkers for cancer diagnosis and prognosis.
  • Targeting these miRNAs offers a promising therapeutic strategy for cancer treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.